ASSERTIO THERAPEUTICS, INC. Payments to Acquire in Process Research and Development
ASSERTIO THERAPEUTICS, INC. reported Payments to Acquire in Process Research and Development of $25.00 million for the 12-month period ending 2015-12-31, per its 10-K filed 2018-03-01.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment · last filed 2018-03-01
- ASSERTIO THERAPEUTICS, INC. payments to acquire in process research and development for fiscal 2015 was $25.00M.
| Period end | Payments to Acquire in Process Research and Development 12 month |
|---|---|
| 2015-12-31 | $25.00M 10-K · filed 2018-03-01 |